We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
963
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.32%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETN icon
1576
Eaton
ETN
$173B
$3.6M 0.01%
+28,557
New +$3.99M
TGR.WS
1577
CALL
DELISTED
Kimbell Tiger Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
TGR.WS
$3.59M 0.01%
+358,423
New +$80.7K
DISAW
1578
CALL
DELISTED
Disruptive Acquisition Corporation I Warrant
DISAW
$3.58M 0.01%
366,662
SWVLW icon
1579
CALL
Swvl Holdings Corp Warrant
SWVLW
$3.57M 0.01%
+552,931
New +$273K
KLAC icon
1580
KLA
KLAC
$252B
$3.57M 0.01%
111,870
-1,039,490
-90% -$35M
LGND icon
1581
Ligand Pharmaceuticals
LGND
$6.42B
$3.56M 0.01%
+63,932
New +$3.63M
KRP icon
1582
Kimbell Royalty Partners
KRP
$1.49B
$3.56M 0.01%
226,794
-154,240
-40% -$2.68M
CPTK
1583
CALL
DELISTED
Crown PropTech Acquisitions
CPTK
$3.54M 0.01%
359,593
CCAIW
1584
CALL
DELISTED
Cascadia Acquisition Corp. Warrant
CCAIW
$3.54M 0.01%
361,957
GACQ
1585
DELISTED
Global Consumer Acquisition Corp. Common Stock
GACQ
$3.54M 0.01%
351,305
MODV
1586
DELISTED
ModivCare
MODV
$3.54M 0.01%
41,849
+30,653
+274% +$3.1M
NGMS
1587
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$3.54M 0.01%
263,752
+4,689
+2% +$63.8K
AWIN
1588
DELISTED
AERWINS Technologies Inc
AWIN
$3.52M 0.01%
3,485
PSNYW icon
1589
CALL
Polestar Automotive Holding ADS Class C-1
PSNYW
$372M
$3.52M 0.01%
+13,333
New +$918K
REVE
1590
DELISTED
Alpine Acquisition Corp
REVE
$3.52M 0.01%
341,840
ADERW
1591
CALL
DELISTED
26 Capital Acquisition Corp Warrant
ADERW
$3.51M 0.01%
358,000
MSA icon
1592
Mine Safety
MSA
$7.45B
$3.51M 0.01%
+29,002
New +$3.61M
GRND icon
1593
Grindr
GRND
$2.91B
$3.51M 0.01%
341,605
TSIB
1594
DELISTED
Tishman Speyer Innovation Corp. II Class A common stock
TSIB
$3.5M 0.01%
357,653
+106,177
+42% +$1.04M
ARGUW
1595
CALL
DELISTED
Argus Capital Corp. Warrant
ARGUW
$3.5M 0.01%
349,998
BSAQ
1596
DELISTED
Black Spade Acquisition Co
BSAQ
$3.5M 0.01%
360,674
PENN icon
1597
PENN Entertainment
PENN
$2.53B
$3.49M 0.01%
114,841
-563,334
-83% -$19M
NAACW
1598
CALL
DELISTED
North Atlantic Acquisition Corporation Warrant
NAACW
$3.49M 0.01%
354,441
TCMD icon
1599
Tactile Systems Technology
TCMD
$657M
$3.48M 0.01%
+477,524
New +$6.05M
HCICW
1600
CALL
DELISTED
Hennessy Capital Investment Corp. V Warrant
HCICW
$3.48M 0.01%
354,997

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 963 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.